Ingalls & Snyder’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$242K Sell
362,550
-6,250
-2% -$4.81K 0.01% 402
2026
Q2
$258K Sell
368,800
-10,500
-3% -$11.1K 0.01% 400
2026
Q1
$618K Sell
379,300
-5,000
-1% -$8.53K 0.02% 260
2025
Q4
$684K Buy
384,300
+159,298
+71% +$332K 0.03% 253
2025
Q3
$542K Buy
+225,002
New +$546K 0.02% 290

Other funds holding NSPR

Ingalls & Snyder's NSPR Position: Q3 2026 in Review

Ingalls & Snyder reduced its InspireMD (NSPR) stake by 1.7% in Q3 2026, selling an estimated $4.81K and leaving 362,550 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #402.

Ingalls & Snyder first reported a position in NSPR in Q3 2025 and has held it in 5 quarters since. The position peaked at $684K in Q4 2025. 27 funds tracked by Wall St. Rank hold NSPR as of Q3 2026.

  • Ingalls & Snyder held 362,550 shares of InspireMD worth $242K as of Q3 2026.
  • Ingalls & Snyder sold 6,250 InspireMD shares in Q3 2026, an estimated $4.81K.
  • InspireMD made up 0.01% of Ingalls & Snyder's portfolio in Q3 2026, its #402 holding.
  • Ingalls & Snyder first reported a position in InspireMD in Q3 2025 and has held it in 5 quarters since.
  • Ingalls & Snyder's InspireMD position peaked at $684K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held InspireMD as of Q3 2026.

Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.